The report provides market dynamics and trends related to the global aerosol delivery devices market. In addition, it presents estimations and forecast of the market. The study estimates revenue generated from the sales of aerosol delivery devices; which are available in the form of dry powder inhalers, metered dose inhalers, and nebulizers. Applications such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory disease indication (diabetes, analgesia, & Parkinson’s disease) have been considered in the market estimation. However, it excludes aerosol delivery devices service revenue. The report comprises revenue generated from cost of pre-filled devices (devices that are available with a drug) such as multi dose dry powder inhalers and metered dose inhalers. In case of some nebulizers and single dose dry powder inhalers, only device price has been considered during the market estimation. Similarly, cost of drugs sold without devices is excluded from the study. Furthermore, the report excludes revenue generated from post-sale services of aerosol delivery devices.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET LANDSCAPE

CHAPTER 4: AEROSOL DELIVERY DEVICES MARKET, BY PRODUCT

CHAPTER 5: AEROSOL DELIVERY DEVICES MARKET, BY APPLICATION 

CHAPTER 6: AEROSOL DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: AEROSOL DELIVERY DEVICES MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES

CHAPTER 9: APPLICATION BASED COMPANY PROFILES